Bristol-Myers introduced CAPOTEN (captopril) the first in a new class of high blood pressure agents called ACE (angiotensin-converting enzyme) inhibitors

, , ,

In 1975, Bristol-Myers researchers Miguel A. Ondetti and David W. Cushman created CAPOTEN (captopril) the first in a new class of high blood pressure agents called ACE (angiotensin-converting enzyme) inhibitors.

CAPOTEN was an important new medical discovery for the treatment of patients with high blood pressure.

Tags:

Source: National Institutes of Health
Credit:

Visit News/History Source
Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.